REN and complement 3 glomerulopathy: We therefore suggested that the effects of renin and its inhibitor aliskiren would be most pronounced in the kidney, especially in complement-mediated diseases, such as C3 glomerulopathy, and that systemic levels of C3 could still be low due to the presence of nephritic factors or complement gene variants (4).